chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Fatigue, Head discomfort, Vaccination complication, Vertigo
Clinical narrative: Chest heaviness; Prolonged vertigo; Head was heavy; It hit her; Fatigue and good fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Chest heaviness), VERTIGO (Prolonged vertigo), HEAD DISCOMFORT (Head was heavy), VACCINATION COMPLICATION (It hit her) and FATIGUE (Fatigue and good fatigue) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04D21A) for COVID-19 vaccination.     Concurrent medical conditions included Hyperacusis (Susceptible to hearing distortion), Vertigo, Hypersensitivity (Hypersensitive to certain sounds) and Hearing disability (Hearing distortion.). Concomitant products included SPIRONOLACTONE (ALDACTONE [SPIRONOLACTONE]) and VITAMINS NOS for an unknown indication.    On 12-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In July 2021, the patient experienced CHEST DISCOMFORT (Chest heaviness), VERTIGO (Prolonged vertigo), HEAD DISCOMFORT (Head was heavy), VACCINATION COMPLICATION (It hit her) and FATIGUE (Fatigue and good fatigue). In July 2021, VERTIGO (Prolonged vertigo) had resolved. At the time of the report, CHEST DISCOMFORT (Chest heaviness), HEAD DISCOMFORT (Head was heavy), VACCINATION COMPLICATION (It hit her) and FATIGUE (Fatigue and good fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided by reporter.   This case was linked to MOD-2021-285106 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Chronic obstructive pulmonary disease
Clinical narrative: Health compromised with COPD; This spontaneous case was reported by a consumer and describes the occurrence of CHRONIC OBSTRUCTIVE PULMONARY DISEASE (Health compromised with COPD) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included COPD (Severe COPD).   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHRONIC OBSTRUCTIVE PULMONARY DISEASE (Health compromised with COPD). At the time of the report, CHRONIC OBSTRUCTIVE PULMONARY DISEASE (Health compromised with COPD) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown   Concomitant medications were not provided. Treatment information was not provided. No lab data provided by reporter.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission in error, Vaccination site pain
Clinical narrative: More than 35 days between Moderna Covid-19 vaccines; sore left injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore left injection site arm) and PRODUCT DOSE OMISSION IN ERROR (More than 35 days between Moderna Covid-19 vaccines) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (sore left injection site arm). On an unknown date, the patient experienced PRODUCT DOSE OMISSION IN ERROR (More than 35 days between Moderna Covid-19 vaccines). At the time of the report, VACCINATION SITE PAIN (sore left injection site arm) outcome was unknown and PRODUCT DOSE OMISSION IN ERROR (More than 35 days between Moderna Covid-19 vaccines) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided. No treatment information was provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Over 35 days since first dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Over 35 days since first dose) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Over 35 days since first dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Over 35 days since first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants and treatment were reported.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Pyrexia, Vaccination site lymphadenopathy
Clinical narrative: cold/flue-like symptoms; fever; the lymph nodes of the same arm of the injection are swollen/problems with his lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (cold/flue-like symptoms), VACCINATION SITE LYMPHADENOPATHY (the lymph nodes of the same arm of the injection are swollen/problems with his lymph nodes) and PYREXIA (fever) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In April 2021, the patient experienced VACCINATION SITE LYMPHADENOPATHY (the lymph nodes of the same arm of the injection are swollen/problems with his lymph nodes). On 22-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INFLUENZA LIKE ILLNESS (cold/flue-like symptoms) and PYREXIA (fever). On 23-Apr-2021, INFLUENZA LIKE ILLNESS (cold/flue-like symptoms) and PYREXIA (fever) had resolved. At the time of the report, VACCINATION SITE LYMPHADENOPATHY (the lymph nodes of the same arm of the injection are swollen/problems with his lymph nodes) outcome was unknown.            No treatment medications are provided  No concomitant medications are provided.  Caller stated that he has wasted a lot of money on this and that it's consistently bothering him.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Dehydration, Feeling abnormal, Heart rate increased, Vertigo
Clinical narrative: Elevated heart rate; Brain fog; Dehydrated; Vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo), DEHYDRATION (Dehydrated), FEELING ABNORMAL (Brain fog) and HEART RATE INCREASED (Elevated heart rate) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 031L20A) for COVID-19 vaccination.     The patient's past medical history included Hashimoto's thyroiditis in September 2000, Upset stomach, Insomnia and Rash. Concurrent medical conditions included Drug allergy (Sensation to all medicine). Concomitant products included LEVOTHYROXINE SODIUM (TIROSINT) for Hashimoto's thyroiditis.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021 at 7:30 AM, the patient experienced VERTIGO (Vertigo). On 17-Mar-2021 at 3:00 AM, the patient experienced DEHYDRATION (Dehydrated). On 22-Mar-2021, the patient experienced FEELING ABNORMAL (Brain fog). On 28-Mar-2021, the patient experienced HEART RATE INCREASED (Elevated heart rate). At the time of the report, VERTIGO (Vertigo), DEHYDRATION (Dehydrated), FEELING ABNORMAL (Brain fog) and HEART RATE INCREASED (Elevated heart rate) had not resolved. Not Provided          No treatment was provided.
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product temperature excursion issue
Clinical narrative: Patient received an expired vaccine; temperature excursion; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine) and PRODUCT TEMPERATURE EXCURSION ISSUE (temperature excursion) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine) and PRODUCT TEMPERATURE EXCURSION ISSUE (temperature excursion). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine) and PRODUCT TEMPERATURE EXCURSION ISSUE (temperature excursion) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  4 Moderna vials affected by temperature excursion (Lot 038C21A). Of those 4 vials, 3 of the vials were used to administer vaccinations to 9 patients over 3 days between 09-Aug-2021 to 11-Aug-2021.  Patient received an expired vaccine past 30 days in the fridge.  No treatment information was reported.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Product storage error; Expired vaccine administered to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient) and PRODUCT STORAGE ERROR (Product storage error) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Product storage error). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient) and PRODUCT STORAGE ERROR (Product storage error) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was provided.  No treatment medication were provided.   This case was linked to MOD-2021-285598 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: got Covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (got Covid) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 immunisation.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (got Covid). At the time of the report, COVID-19 (got Covid) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant drugs were provided No treatment drugs were provided
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: feeling that he worked out hard and that his left arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (feeling that he worked out hard and that his left arm was sore) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In July 2021, the patient experienced PAIN IN EXTREMITY (feeling that he worked out hard and that his left arm was sore). The patient was treated with GABAPENTIN for Adverse event, at an unspecified dose and frequency and BACLOFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (feeling that he worked out hard and that his left arm was sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was provided.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Product dose omission issue, Vaccination site erythema, Vaccination site pain
Clinical narrative: Patient has not received her 2nd shot; Redness around the injection site; Pain soreness around the injection site; Dizzy; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient has not received her 2nd shot), DIZZINESS (Dizzy), VACCINATION SITE ERYTHEMA (Redness around the injection site) and VACCINATION SITE PAIN (Pain soreness around the injection site) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced DIZZINESS (Dizzy). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient has not received her 2nd shot), VACCINATION SITE ERYTHEMA (Redness around the injection site) and VACCINATION SITE PAIN (Pain soreness around the injection site). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient has not received her 2nd shot) had resolved and DIZZINESS (Dizzy), VACCINATION SITE ERYTHEMA (Redness around the injection site) and VACCINATION SITE PAIN (Pain soreness around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant Medications details were provided. No Treatment Medications details were provided.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Right after the first dose, he felt it was hard to breathe but went away after 15 minutes; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Right after the first dose, he felt it was hard to breathe but went away after 15 minutes) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 638C21A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy, Drug allergy (Codeine), Drug allergy (Tramadol), Drug allergy (Toradol), Drug allergy (Gabapentin) and Fruit allergy (mangoes).    On 09-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jul-2021, the patient experienced DYSPNOEA (Right after the first dose, he felt it was hard to breathe but went away after 15 minutes). On 09-Jul-2021, DYSPNOEA (Right after the first dose, he felt it was hard to breathe but went away after 15 minutes) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported.  It was reported that patient did not take any medication with the symptoms, just increased his water intake and also confirms that patient was not taking any regular prescribed medications or any supplements.   This case was linked to MOD-2021-284335 (Patient Link).
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine administered to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 12-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient). On 12-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   ARNP  reported that 6 patients received the first dose of expired Moderna COVID-19 vaccine on 12AUG2021.  It was reported that the vial did not undergo any previous temperature excursions.  No concomitant medications were reported.  No treatment information was reported.   This case was linked to MOD21-129698, MOD21-129760, MOD21-129763, MOD21-129764, MOD21-129765 (E2B Linked Report). This case was linked to MOD-2021-285598 (Patient Link).; Sender's Comments:  MOD21-129698: MOD21-129760: MOD21-129763: MOD21-129764: MOD21-129765:
Sex: U
Vaccine: COVID19
Symptoms: Cardiomegaly
Clinical narrative: Enlarged heart; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CARDIOMEGALY (Enlarged heart) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CARDIOMEGALY (Enlarged heart). At the time of the report, CARDIOMEGALY (Enlarged heart) had not resolved.            No concomitant medications were provided by reporter. No treatment medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Expired device used, Product storage error
Clinical narrative: Patient received an expired vaccine; received an expired vaccine past 30 days in the fridge; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED DEVICE USED (Patient received an expired vaccine) and PRODUCT STORAGE ERROR (received an expired vaccine past 30 days in the fridge) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED DEVICE USED (Patient received an expired vaccine) and PRODUCT STORAGE ERROR (received an expired vaccine past 30 days in the fridge). At the time of the report, EXPIRED DEVICE USED (Patient received an expired vaccine) and PRODUCT STORAGE ERROR (received an expired vaccine past 30 days in the fridge) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant information was reported.  No treatment information was reported.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Feeling hot, Pain, Vaccination site swelling
Clinical narrative: Raised, hot, and painful on the right calf; Varicose Veins bulging out; Pain in the right side of body; Bulge on the injection site; Pain in the left knee; Has No Energy; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Has No Energy), FEELING HOT (Raised, hot, and painful on the right calf), VARICOSE VEIN (Varicose Veins bulging out), PAIN (Pain in the right side of body) and VACCINATION SITE SWELLING (Bulge on the injection site) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939982) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Aug-2021, the patient experienced ASTHENIA (Has No Energy), PAIN (Pain in the right side of body), VACCINATION SITE SWELLING (Bulge on the injection site) and ARTHRALGIA (Pain in the left knee). On 03-Aug-2021, the patient experienced FEELING HOT (Raised, hot, and painful on the right calf) and VARICOSE VEIN (Varicose Veins bulging out). On 06-Aug-2021, FEELING HOT (Raised, hot, and painful on the right calf) and VARICOSE VEIN (Varicose Veins bulging out) had resolved. At the time of the report, ASTHENIA (Has No Energy), PAIN (Pain in the right side of body), VACCINATION SITE SWELLING (Bulge on the injection site) and ARTHRALGIA (Pain in the left knee) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Varicose vein
Clinical narrative: Raised, hot, and painful on the right calf; Varicose Veins bulging out; Pain in the right side of body; Bulge on the injection site; Pain in the left knee; Has No Energy; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Has No Energy), FEELING HOT (Raised, hot, and painful on the right calf), VARICOSE VEIN (Varicose Veins bulging out), PAIN (Pain in the right side of body) and VACCINATION SITE SWELLING (Bulge on the injection site) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939982) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Aug-2021, the patient experienced ASTHENIA (Has No Energy), PAIN (Pain in the right side of body), VACCINATION SITE SWELLING (Bulge on the injection site) and ARTHRALGIA (Pain in the left knee). On 03-Aug-2021, the patient experienced FEELING HOT (Raised, hot, and painful on the right calf) and VARICOSE VEIN (Varicose Veins bulging out). On 06-Aug-2021, FEELING HOT (Raised, hot, and painful on the right calf) and VARICOSE VEIN (Varicose Veins bulging out) had resolved. At the time of the report, ASTHENIA (Has No Energy), PAIN (Pain in the right side of body), VACCINATION SITE SWELLING (Bulge on the injection site) and ARTHRALGIA (Pain in the left knee) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Hot flush, Joint swelling, Pain in extremity, Taste disorder
Clinical narrative: all of the sudden her ankles are swollen which is not normal; Medicine taste in her mouth; Arm hurts; Having hot flashes; This spontaneous case was reported by a consumer and describes the occurrence of TASTE DISORDER (Medicine taste in her mouth), PAIN IN EXTREMITY (Arm hurts), HOT FLUSH (Having hot flashes) and JOINT SWELLING (all of the sudden her ankles are swollen which is not normal) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 078C21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy. Concomitant products included LORATADINE for an unknown indication.    On 10-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Aug-2021, the patient experienced TASTE DISORDER (Medicine taste in her mouth), PAIN IN EXTREMITY (Arm hurts) and HOT FLUSH (Having hot flashes). On 12-Aug-2021, the patient experienced JOINT SWELLING (all of the sudden her ankles are swollen which is not normal). At the time of the report, TASTE DISORDER (Medicine taste in her mouth), PAIN IN EXTREMITY (Arm hurts), HOT FLUSH (Having hot flashes) and JOINT SWELLING (all of the sudden her ankles are swollen which is not normal) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was also not reported.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age, Vaccination site pain
Clinical narrative: Patient is14 years old and he presented at the clinic and got a vaccine; Sore arm; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient is14 years old and he presented at the clinic and got a vaccine) and VACCINATION SITE PAIN (Sore arm) in a 14-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient is 14 years old and he presented at the clinic and got a vaccine) and VACCINATION SITE PAIN (Sore arm). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient is 14 years old and he presented at the clinic and got a vaccine) had resolved and VACCINATION SITE PAIN (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter.  No treatment information was provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received an expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The nurse reported that the shipment of vaccines were received on 08-Jul-2021 to a different team and was placed in the refrigerator. The vaccines were received to her on 30-Jul-2021  The number of Moderna vials affected were 4 vials of those 3 of the vials were used to administer vaccinations to 9 patients over 3 days from 09-Aug-2021 to 11-Aug-2021.  No Concomitant medications was provided by reporter. No treatment information was provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: SARS-CoV-2 test false positive, SARS-CoV-2 test positive
Clinical narrative: 2-3 teachers who tested positive for COVID (via rapid test)after the vaccination went to the doctor they were negative; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST FALSE POSITIVE (2-3 teachers who tested positive for COVID (via rapid test)after the vaccination went to the doctor they were negative) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST FALSE POSITIVE (2-3 teachers who tested positive for COVID (via rapid test)after the vaccination went to the doctor they were negative). At the time of the report, SARS-COV-2 TEST FALSE POSITIVE (2-3 teachers who tested positive for COVID (via rapid test)after the vaccination went to the doctor they were negative) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test positive: positive (Positive) Rapid test.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported.  No treatment medication were reported.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: tingling in leg; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling in leg) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Aug-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PARAESTHESIA (tingling in leg). At the time of the report, PARAESTHESIA (tingling in leg) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: injection site where it's sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (injection site where it's sore) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced VACCINATION SITE PAIN (injection site where it's sore). At the time of the report, VACCINATION SITE PAIN (injection site where it's sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medication was not provided.   Treatment information was not provided.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Ear discomfort, Fatigue, Feeling hot, Feeling of body temperature change, Hyperhidrosis
Clinical narrative: Cloggeal ear; flu like symptoms; Skin hot touch; feeling really hot,then really cold; Sweating; Eustachian nose inflammation; Exhausted; Pain all over body; Systemic Inflammation; This spontaneous case was reported by a consumer and describes the occurrence of INFLAMMATION (Systemic Inflammation), EAR DISCOMFORT (Cloggeal ear), INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING HOT (Skin hot touch) and FEELING OF BODY TEMPERATURE CHANGE (feeling really hot,then really cold) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L70A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Bee sting hypersensitivity, Drug allergy, Drug allergy, Drug allergy, Fibromyalgia, Complex regional pain syndrome and Pituitary tumor NOS. Concomitant products included PANTOPRAZOLE SODIUM SESQUIHYDRATE (PANTOPRAZOLE 40) for Gastroesophageal reflux disease, HYDROCODONE for Pain.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced INFLAMMATION (Systemic Inflammation). On an unknown date, the patient experienced EAR DISCOMFORT (Cloggeal ear), INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING HOT (Skin hot touch), FEELING OF BODY TEMPERATURE CHANGE (feeling really hot,then really cold), HYPERHIDROSIS (Sweating), NASAL INFLAMMATION (Eustachian nose inflammation), FATIGUE (Exhausted) and MYALGIA (Pain all over body). The patient was treated with PREDNISONE at an unspecified dose and frequency. At the time of the report, INFLAMMATION (Systemic Inflammation) had resolved with sequelae and EAR DISCOMFORT (Cloggeal ear), INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING HOT (Skin hot touch), FEELING OF BODY TEMPERATURE CHANGE (feeling really hot,then really cold), HYPERHIDROSIS (Sweating), NASAL INFLAMMATION (Eustachian nose inflammation), FATIGUE (Exhausted) and MYALGIA (Pain all over body) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Had done lots of blood work done. Blood work all normal   This case was linked to MOD-2021-031548 (Patient Link).
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Inflammation, Influenza like illness, Myalgia, Nasal inflammation
Clinical narrative: Cloggeal ear; flu like symptoms; Skin hot touch; feeling really hot,then really cold; Sweating; Eustachian nose inflammation; Exhausted; Pain all over body; Systemic Inflammation; This spontaneous case was reported by a consumer and describes the occurrence of INFLAMMATION (Systemic Inflammation), EAR DISCOMFORT (Cloggeal ear), INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING HOT (Skin hot touch) and FEELING OF BODY TEMPERATURE CHANGE (feeling really hot,then really cold) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L70A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Bee sting hypersensitivity, Drug allergy, Drug allergy, Drug allergy, Fibromyalgia, Complex regional pain syndrome and Pituitary tumor NOS. Concomitant products included PANTOPRAZOLE SODIUM SESQUIHYDRATE (PANTOPRAZOLE 40) for Gastroesophageal reflux disease, HYDROCODONE for Pain.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced INFLAMMATION (Systemic Inflammation). On an unknown date, the patient experienced EAR DISCOMFORT (Cloggeal ear), INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING HOT (Skin hot touch), FEELING OF BODY TEMPERATURE CHANGE (feeling really hot,then really cold), HYPERHIDROSIS (Sweating), NASAL INFLAMMATION (Eustachian nose inflammation), FATIGUE (Exhausted) and MYALGIA (Pain all over body). The patient was treated with PREDNISONE at an unspecified dose and frequency. At the time of the report, INFLAMMATION (Systemic Inflammation) had resolved with sequelae and EAR DISCOMFORT (Cloggeal ear), INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING HOT (Skin hot touch), FEELING OF BODY TEMPERATURE CHANGE (feeling really hot,then really cold), HYPERHIDROSIS (Sweating), NASAL INFLAMMATION (Eustachian nose inflammation), FATIGUE (Exhausted) and MYALGIA (Pain all over body) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Had done lots of blood work done. Blood work all normal   This case was linked to MOD-2021-031548 (Patient Link).
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Antibody test, Bile acid malabsorption, Diarrhoea, Feeding disorder, Illness
Clinical narrative: very sick; diarrhea; She was having bile coming out of her and her body kept pushing out; couldn't eat; lost 13 lbs; didn't receive the 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (very sick), DIARRHOEA (diarrhea), BILE ACID MALABSORPTION (She was having bile coming out of her and her body kept pushing out), FEEDING DISORDER (couldn't eat) and WEIGHT DECREASED (lost 13 lbs) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Anal cancer.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (very sick), DIARRHOEA (diarrhea), BILE ACID MALABSORPTION (She was having bile coming out of her and her body kept pushing out), FEEDING DISORDER (couldn't eat), WEIGHT DECREASED (lost 13 lbs) and PRODUCT DOSE OMISSION ISSUE (didn't receive the 2nd dose). At the time of the report, ILLNESS (very sick), DIARRHOEA (diarrhea), BILE ACID MALABSORPTION (She was having bile coming out of her and her body kept pushing out) and WEIGHT DECREASED (lost 13 lbs) outcome was unknown, FEEDING DISORDER (couldn't eat) was resolving and PRODUCT DOSE OMISSION ISSUE (didn't receive the 2nd dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: positive (Positive) antibody test that shows positive and says 60.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  Treatment medication was not provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, Weight decreased
Clinical narrative: very sick; diarrhea; She was having bile coming out of her and her body kept pushing out; couldn't eat; lost 13 lbs; didn't receive the 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (very sick), DIARRHOEA (diarrhea), BILE ACID MALABSORPTION (She was having bile coming out of her and her body kept pushing out), FEEDING DISORDER (couldn't eat) and WEIGHT DECREASED (lost 13 lbs) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Anal cancer.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (very sick), DIARRHOEA (diarrhea), BILE ACID MALABSORPTION (She was having bile coming out of her and her body kept pushing out), FEEDING DISORDER (couldn't eat), WEIGHT DECREASED (lost 13 lbs) and PRODUCT DOSE OMISSION ISSUE (didn't receive the 2nd dose). At the time of the report, ILLNESS (very sick), DIARRHOEA (diarrhea), BILE ACID MALABSORPTION (She was having bile coming out of her and her body kept pushing out) and WEIGHT DECREASED (lost 13 lbs) outcome was unknown, FEEDING DISORDER (couldn't eat) was resolving and PRODUCT DOSE OMISSION ISSUE (didn't receive the 2nd dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: positive (Positive) antibody test that shows positive and says 60.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  Treatment medication was not provided.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Hot flush, Peripheral swelling, Pigmentation disorder
Clinical narrative: hot flashes; spots on hand and feet; feels like cant process thoughts; Shortness of breath; dizziness; swelling in feet jaw and left hand; swelling in feet jaw and left hand; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (hot flashes), PIGMENTATION DISORDER (spots on hand and feet), THOUGHT BLOCKING (feels like cant process thoughts), DYSPNOEA (Shortness of breath) and DIZZINESS (dizziness) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003E21A.) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced HOT FLUSH (hot flashes), PIGMENTATION DISORDER (spots on hand and feet), THOUGHT BLOCKING (feels like cant process thoughts), DYSPNOEA (Shortness of breath), DIZZINESS (dizziness), SWELLING FACE (swelling in feet jaw and left hand) and PERIPHERAL SWELLING (swelling in feet jaw and left hand). The patient was treated with ALBUTEROL [SALBUTAMOL] for Breathing difficult, at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) for Fever and Swelling, at an unspecified dose and frequency. At the time of the report, HOT FLUSH (hot flashes), PIGMENTATION DISORDER (spots on hand and feet), THOUGHT BLOCKING (feels like cant process thoughts), DYSPNOEA (Shortness of breath), DIZZINESS (dizziness), SWELLING FACE (swelling in feet jaw and left hand) and PERIPHERAL SWELLING (swelling in feet jaw and left hand) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No Medical History information was reported.   This case was linked to MOD-2021-285527 (Patient Link).   Reporter did not allow further contact
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face, Thought blocking
Clinical narrative: hot flashes; spots on hand and feet; feels like cant process thoughts; Shortness of breath; dizziness; swelling in feet jaw and left hand; swelling in feet jaw and left hand; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (hot flashes), PIGMENTATION DISORDER (spots on hand and feet), THOUGHT BLOCKING (feels like cant process thoughts), DYSPNOEA (Shortness of breath) and DIZZINESS (dizziness) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003E21A.) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced HOT FLUSH (hot flashes), PIGMENTATION DISORDER (spots on hand and feet), THOUGHT BLOCKING (feels like cant process thoughts), DYSPNOEA (Shortness of breath), DIZZINESS (dizziness), SWELLING FACE (swelling in feet jaw and left hand) and PERIPHERAL SWELLING (swelling in feet jaw and left hand). The patient was treated with ALBUTEROL [SALBUTAMOL] for Breathing difficult, at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) for Fever and Swelling, at an unspecified dose and frequency. At the time of the report, HOT FLUSH (hot flashes), PIGMENTATION DISORDER (spots on hand and feet), THOUGHT BLOCKING (feels like cant process thoughts), DYSPNOEA (Shortness of breath), DIZZINESS (dizziness), SWELLING FACE (swelling in feet jaw and left hand) and PERIPHERAL SWELLING (swelling in feet jaw and left hand) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No Medical History information was reported.   This case was linked to MOD-2021-285527 (Patient Link).   Reporter did not allow further contact
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Erythema, Fatigue, Flushing, Headache
Clinical narrative: Extreme Fatigue; Pain moved from one shoulder to the other, down her spine and tail bone; Red Flushing of the Face; Red Flushing of the Face; Severe Headache; Severe body ache; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (Red Flushing of the Face), ERYTHEMA (Red Flushing of the Face), HEADACHE (Severe Headache), MYALGIA (Severe body ache) and ARTHRALGIA (Pain moved from one shoulder to the other, down her spine and tail bone) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 034C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (never did a PCR test to confirm that in fact she had COVID-19 in 2020.) in 2020.    On 21-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jul-2021, the patient experienced FLUSHING (Red Flushing of the Face), ERYTHEMA (Red Flushing of the Face), HEADACHE (Severe Headache) and MYALGIA (Severe body ache). On 22-Jul-2021, the patient experienced ARTHRALGIA (Pain moved from one shoulder to the other, down her spine and tail bone). On 24-Jul-2021, the patient experienced FATIGUE (Extreme Fatigue). The patient was treated with TYLENOL for Pain, at an unspecified dose and frequency. On 21-Jul-2021, FLUSHING (Red Flushing of the Face) and ERYTHEMA (Red Flushing of the Face) had resolved. At the time of the report, HEADACHE (Severe Headache), MYALGIA (Severe body ache), ARTHRALGIA (Pain moved from one shoulder to the other, down her spine and tail bone) and FATIGUE (Extreme Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided. Two weeks after vaccination, the patient visited her doctor's office. The ARNP told her that some spike protein may have deposited into her joints, that is why she is having so much pain. Also the ARNP told her that because she had COVID-19 Disease early on, she had this reaction to the vaccine and experienced severe side effects. ARNP prescribed Anti-Inflammatory medication which helped with the pain. But the patient states that she is still aware the problem is there, even after taking the anti-inflammatory medication. Patient stated that she was very unhappy.